How can the EU increase the resilience of value chains in the health industry?
How can AI help us fight through a pandemic crisis?
Can the EU handle biological threats?
Reconciling health and privacy needs.
This Policy Contribution proposes a staged support scheme to tackle the COVID-19 vaccine challenge and a moon shot programme to meet the challenge of future pandemics.
How can cohesion funds help the National, regional and local communities that are on the frontline in countering the coronavirus and the resulting economic crisis.
As countries are struggling with the COVID-19 pandemic, shortages in medical equipment led to EU export controls and war-time like procurement of respirators. While the crisis is still unfolding, there is a debate on whether the EU is too reliant on global value chains for medical goods. Looking at the world market of medical goods for the EU, we argue that self-sufficiency is the wrong approach. Global medical markets are to the benefits of the EU and stockpiling and preparation are more effective in preparing for emergencies.
This is the second event in our series with the Financial Times, where Paolo Gentiloni will discuss the European response to the coronavirus crisis.
The silence from Brussels could be as damaging as the silence on Italian streets
The panellists at this event reviewed the general state of health as well as the digitalisation in the industry.
In a new podcast series looking specifically at Bruegel research, Zsolt Darvas expounds on the themes of a research paper he has co-written on the macroeconomic implications of healthcare.
Health-care systems play a crucial role in supporting human health. They also have major macroeconomic implications, an aspect that is not always properly acknowledged. Using a standard method to measure efficiency, data envelopment analysis (DEA), the authors find significant differences between countries. This finding calls for policy responses.